WCN26-3843 PROGNOSTIC IMPACT OF SEVERE KIDNEY IMPAIRMENT AT TREATMENT INITIATION IN PATIENTS WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS

Read full text Summarise with VIRAT
Authors: Akihito Tanaka, Chikao Onogi, Kazuhiro Furuhashi, Yu Watanabe, Eri Koshi-Ito, Shoichi Maruyama
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) often affects elderly individuals, in whom excessive immunosuppression has been shown to worsen prognosis. Consequently, treatment strategies have shifted toward avoiding excessive immunosuppression. In recent years, various new therapeutic agents have become available, expanding treatment options for AAV. However, despite these advances, the overall improvement in patient outcomes has plateaued. Previously, we reported that patients who showed severe kidney impairment within the first two weeks of treatment had poorer long-term prognosis, suggesting that early identification and intensive management of such patients might improve prognosis.

Fields of Study & Subjects

Vasculitis and related conditions Renal Diseases and Glomerulopathies Renal Transplantation Outcomes and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104762–104762
Publication date
25 March 2026
Language
EN